Leverty Financial Group’s Boston Scientific BSX Stock Holding History

Leverty Financial Group’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-3,003	Closed	-$286K	–	47
2025 Q4	$286K	Sell	3,003 -22	-0.7%	-$2.16K	0.07%	36
2025 Q3	$295K	Buy	3,025 +12	+0.4%	+$1.24K	0.08%	33
2025 Q2	$324K	Sell	3,013 -964	-24%	-$97.5K	0.1%	31
2025 Q1	$401K	Buy	3,977 +910	+30%	+$91.6K	0.16%	26
2024 Q4	$274K	Hold	3,067	–	–	0.14%	26
2024 Q3	$257K	Sell	3,067 -53	-2%	-$4.18K	0.14%	28
2024 Q2	$240K	Sell	3,120 -75	-2%	-$5.49K	0.14%	27
2024 Q1	$219K	Buy	+3,195	New	+$205K	0.13%	29

Other funds holding BSX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Leverty Financial Group's BSX Position: Q1 2026 in Review

Leverty Financial Group sold out of Boston Scientific (BSX) in Q1 2026, closing a stake of 3,003 shares — an estimated $286K sold.

Leverty Financial Group first reported a position in BSX in Q1 2024 and held it in 8 quarters. The position peaked at $401K in Q1 2025. 1,676 funds tracked by Wall St. Rank hold BSX as of Q1 2026.

Leverty Financial Group reported no remaining Boston Scientific position as of Q1 2026 after selling out during the quarter.
Leverty Financial Group sold 3,003 Boston Scientific shares in Q1 2026, an estimated $286K.
Leverty Financial Group first reported a position in Boston Scientific in Q1 2024 and held it in 8 quarters.
Leverty Financial Group's Boston Scientific position peaked at $401K in Q1 2025.
1,676 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.

Based on Leverty Financial Group's 13F filing for Q1 2026, filed 9 Apr 2026.